
    
      The aim of the study is to assess repeated cycles of 3 weekly injections of CYT107 in
      patients immune non-responders infected with HIV.

      Eighty patients will be recruited to study the biological activity and safety of repeated
      cycles of CYT107 at 20 Âµg/kg/week over 2 weeks, for a maximum of 4 cycles within 21 months
      and a maximum of 3 cycles within 12 months. The entire study will cover a period of 24
      months.

      During the study visits the following may be done:

        -  medical history, physical examination, blood test every visit

        -  EKG

        -  chest X-Ray

        -  liver/spleen ultrasound
    
  